Bioxyne Ltd has released a press release.
FY25 Revenue Guidance Upgrade
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Bioxyne
- BXN Signs Exclusive $7m Manufacturing and Supply Agreement
- Bioxyne Raises A$3 million in Capital Raise
- Trading Halt
- Pause in Trading
- BXN H1 FY25 Results Presentation
Later from Bioxyne
- Certificate GMP Compliance EU, UK, Singapore & Canada
- Enters German Market Euro3.2m Manufacturing & Supply Agmt
- Investor Presentation Update
- Bioxyne Updated Investor Presentation
- 30 June 2025 Appendix 4C Revised
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne